Disclosures for "Reduced humoral immune response after mRNA vaccination correlates with breakthrough SARS-CoV-2 infection in ocrelizumab-treated multiple sclerosis patients ")
-
Dr. Novak has nothing to disclose.
-
Mr. Bajwa has nothing to disclose.
-
The institution of Prof. Coia has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Tillotts. The institution of Prof. Coia has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Tillotts. The institution of Prof. Coia has received research support from Tillotts.
-
Dr. Nilsson has received publishing royalties from a publication relating to health care.
-
Dr. Nielsen has nothing to disclose.
-
Mrs. Holm has nothing to disclose.
-
Dr. Ostergaard has nothing to disclose.
-
Miss Hvidt has nothing to disclose.
-
Mr. BYG has nothing to disclose.
-
Prof. Johansen has nothing to disclose.
-
Ms. Mittl has nothing to disclose.
-
William Rowles has nothing to disclose.
-
Dr. Zamvil has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Alexion. Dr. Zamvil has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Genzyme. Dr. Zamvil has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for AAN. Dr. Zamvil has received personal compensation in the range of $500-$4,999 for serving as a Advisory Board with Genzyme. Dr. Zamvil has received personal compensation in the range of $500-$4,999 for serving as a Advisory Board with Genentech. Dr. Zamvil has received personal compensation in the range of $500-$4,999 for serving as a Advisory Board with Alexion.
-
Dr. Bove has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Biogen. Dr. Bove has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Horizon. Dr. Bove has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. Dr. Bove has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for EMD Serono. Dr. Bove has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Genzyme Sanofi. Dr. Bove has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Dr. Bove has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for TG Therapeutics. Dr. Bove has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Jansen. Dr. Bove has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alexion. The institution of Dr. Bove has received research support from Biogen. The institution of Dr. Bove has received research support from Roche Genentech. The institution of Dr. Bove has received research support from Novartis.
-
Dr. Sabatino has received research support from Novartis. Dr. Sabatino has received research support from Roche/Genentech. Dr. Sabatino has received personal compensation in the range of $500-$4,999 for serving as a CME course instructor with eMultiple Sclerosis Review. Dr. Sabatino has received personal compensation in the range of $500-$4,999 for serving as a CME course instructor with Physician Education Resource.
-
Tobias Sejbaek has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen, Merck, Novartis, Roche. Tobias Sejbaek has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Biogen, Merck, Novartis, Teva. The institution of Tobias Sejbaek has received research support from Biogen, Merck, Novartis, Roche.